A comparative study of stakeholder views on take-home naloxone services

Journal of Substance Use

Volumn 17, Issue 5-6, 2012, Pages 430-441

  Hill, Duncan ^a   McAuley, Andrew ^b  

^a NHS LANARKSHIRE   (United Kingdom)

^b NHS HEALTH SCOTLAND   (United Kingdom)

Author keywords

Naloxone; Stakeholders; Take home

Indexed keywords

NALOXONE;

ADULT; AMBULANCE; ARTICLE; COMPARATIVE STUDY; DRUG OVERDOSE; FEMALE; HEALTH SERVICE; HEALTH SURVEY; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACIST; PRIORITY JOURNAL; QUANTITATIVE STUDY; QUESTIONNAIRE; RESUSCITATION;

EID: 84868669566     PISSN: 14659891     EISSN: 14759942     Source Type: Journal    
DOI: 10.3109/14659891.2011.595275     Document Type: Article

References (26)

1. Advisory Committee of the Misuse of Drugs. (2009). Letter to MHRA Dated 22nd April 2009. Retrieved from http://webarchive.nationalarchives.gov.uk/ 20100419081707/http://drugs.homeoffice.gov.uk/publicationsearch/acmd/ mhra-naloxone2835.pdf?view=Binary
2. Best, D., Man, L., Zador, D., Darke, S., Bird, S., Strang, J., & Ashton, M. (2001). Overdosing on opiates Part 2: Prevention. Findings, 4, 4-18.
3. Buajordet, I., Næss, A. C., Jacobsen, D., & Brørs, O. (2004). Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. European Journal of Emergency Medicine, 11, 19-23.
4. Burris. S., Noreland, J., & Edlin, B. (2001). Legal aspects of providing naloxone to heroin users in the United States. The International Journal on Drug Policy, 12, 237-248. (Pubitemid 32772601)
5. Casey, J., Hay, G., Godfrey, C., & Parrott, S. (2009). Assessing scale and impact of illicit drug markets in Scotland. Edinburgh: Scottish Government.
6. Gaston, R., Best, D., Manning, V., & Day, E. (2009). Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduction Journal, 6, 26.
7. General Register Office for Scotland. (2010). Drug-related deaths in Scotland in 2009. Retrieved from http://www.gro-scotland.gov.uk/statistics/ theme/vital-events/deaths/drug-related/drd2009/index.html
8. Hay, G., Gannon, M., Casey, J., & McKeganey, N. (2009). Estimating the national and local prevalence of problem drug use in Scotland: Executive report. Edinburgh, ISD Scotland.
9. ISD. (2010). Drug misuse statistics Scotland. Edinburgh: Information Services Division.
10. Kerr, D., Dietze, P., Kelly, A., & Jolley, D. (2008). Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: Perspectives of intranasal administration. Journal of Urban Health, 85, 3.
11. Kim, D., Irwin, K., & Khoshnood, K. (2009). Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. American Journal of Public Health, 99(3), 402-407.
12. Lagu, T., Anderson, B. J., & Stein, M. (2006). Overdoses among friends: Drug users are willing to administer naloxone to others. Journal of Substance Abuse Treatment, 25, 89-96.
13. Lenton, S., & Hargreaves, K. (2000). Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? The Medical Journal of Australia,173, 260-263.
14. Maxwell, S., Bigg, D., Stanczykiewicz, K., & Cralberg-Racich, S. (2006). Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. Journal of Addictive Diseases, 30, 129-133.
15. McAuley, A., Lindsay, G., Woods, M., & Louttit, D. (2010). Responsible management and use of personal takehome naloxone supply: A pilot project. Drugs: Education, Prevention and Policy, 4, 388-399.
16. National Forum on Drug-related Deaths in Scotland. (2007). Annual report 2007. Edinburgh: Scottish Government.
17. Rosenberg, H., Melville, J., & McLean, P. C. (2002). Acceptability and availability of pharmacological interventions for substance misuse by British NHS treatment services. Addiction, 97, 59-65. (Pubitemid 34038193)
18. Scottish Government. (2008). The road to recovery: A new approach to tackling Scotland's drug problem. Edinburgh: Scottish Government.
19. Scottish Government. (2010). Tackling drug deaths. Retrieved from http://www.scotland.gov.uk/News/Releases/2010/08/17095105
20. Seal, K., Kral, A., Gee, L., Moore, L. D., Bluthenthal, R. N., Lorvick, J., & Edlin, B. R. (2001). Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. American Journal of Public Health, 91(11), 1842-1846. (Pubitemid 33031743)
21. Seal, K. H., Downing, M., Kral, A. H., Singleton-Banks, S., Hammond, J. P., Lorvick, J., Ciccarone, D., & Edlin, B. R. (2003). Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. Journal of Urban Health, 80(2), 291-301. (Pubitemid 37486665)
22. Seal, K. H., Thawley, R., Gee, L., Bamberger, J., Kral, A. H., Ciccarone, D., & Edlin, B. R. (2005). Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot study. Journal of Urban Health, 82, 303-311. (Pubitemid 41214946)
23. Strang, J., Darke, S., Hall, W., Farrell, M., & Ali, R. (1996). Heroin overdose: The case for take home naloxone. British Medical Journal, 312, 1435-1436. (Pubitemid 26170613)
24. Strang, J., Manning, V., Mayet, S., Best, D., Titherington, E., Santana, L., & Semmler, C. (2008a). Overdose training and take-home naloxone for opiate users: Prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction, 103, 1648-1657.
25. Strang, J., Manning, V., Mayet, S., Titherington, E., Offor, L., Semmler, C., &Williams, A. (2008b). Family carers and the prevention of heroin overdose deaths: Unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone. Drugs: Education, Prevention and Policy, 15(2), 211-218.
26. Strang, J., Powis, B., Best, D., Vingoe, L., Griffiths, P., Taylor, C., & Gossop, M. (1999). Preventing opiate overdose fatalities with take home naloxone: Pre launch study of possible impact and accessibility. Addiction, 94(2), 199-204. (Pubitemid 29068960)